In the news

November 1, 2019

Cancer Bioinformatics Q&A – Purdue and IU Partners in Cutting Edge Cancer Technology

The Cancer Bioinformatics Core is a shared facility between IU Simon Cancer Center (IUSCC) and Purdue University Center for Cancer Research (PUCCR). Jun Wan, Ph.D., serves as director of the core at IUSCC. He and Nadia Atallah Lanman, Ph.D., manager of the core at PUCCR, answered questions about the facility.

September 30, 2019

Can herbicides cause breast cancer? Purdue and INSERM scientists discover a piece to the puzzle.

Scientists at Purdue University and France’s Institut de Cancérologie de L’Ouest (ICO) have discovered that glyphosate, the primary ingredient in some widely used herbicides and pesticides, can lead to breast cancer under certain conditions.

September 17, 2019

A case for personalized medicine in the search for answers about cancer

Purdue University, Indiana University scientists work together to find data-driven solutions

September 3, 2019

Epigenetics offers puzzling twists and turns, but also possible cancer treatments

Learning how to switch certain genes on or off — the focus of the field of epigenetics — could make cancer therapies such as chemotherapy or immunotherapy much more effective, says Purdue scientist Emily Dykhuizen.

August 27, 2019

Big data approach to cancer is focus of new Purdue partnership

Improving the use of biostatistics, predictive modeling and data science in cancer research is the focus of a new partnership between Purdue University and the Frederick National Laboratory for Cancer Research.

August 26, 2019

Structural Biology Used to Gain Insight into the Mechanism of Action of Covalent Inhibitors of the Deubiquitinase UCHL1

The insight into mechanism of action and structural analysis learned from this work provides information for the future design of potent and selective UCHL1 covalent inhibitors.

August 20, 2019

‘A first for cancer research’: New approach to study tumors

Sophie Lelièvre, a professor of cancer pharmacology at Purdue University, is leading a team of scientists to create tumor models in 10 days that are much closer in size to the ones found in the body and readily mimic the pathological characteristics of human cancers.

New anticancer agents have potential to better control tumor growth in nearly every cancer type

Novel set of G-quadruplex stabilizers may help stop gene from driving tumor growth in hundreds of cancers

Purdue ranks 12th among worldwide universities granted U.S. utility patents for 2018

Purdue receives 126 U.S. utility patents, finishing in the top 20 for fifth straight year

Tyler Trent’s donated cells to help trio of new research projects

Purdue University superfan’s legacy lives on through cancer collaborations